JP3072584B2 - Skin stratum corneum water content increasing agent - Google Patents
Skin stratum corneum water content increasing agentInfo
- Publication number
- JP3072584B2 JP3072584B2 JP5029477A JP2947793A JP3072584B2 JP 3072584 B2 JP3072584 B2 JP 3072584B2 JP 5029477 A JP5029477 A JP 5029477A JP 2947793 A JP2947793 A JP 2947793A JP 3072584 B2 JP3072584 B2 JP 3072584B2
- Authority
- JP
- Japan
- Prior art keywords
- skin
- stratum corneum
- water content
- increasing agent
- increasing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Landscapes
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Description
【0001】[0001]
【産業上の利用分野】本発明は、皮膚角質層水分量増加
剤及びそれを含有する組成物に関し、詳しくは、ショウ
ガ抽出物に含まれるジンゲロール、ショウガオールを有
効成分として含有する皮膚角質層水分量増加剤及びそれ
を含む組成物に関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to an agent for increasing the water content of the stratum corneum of the skin and a composition containing the same, and more particularly, to a water content of the skin stratum corneum containing gingerol and ginger contained in a ginger extract as active ingredients. The present invention relates to an amount increasing agent and a composition containing the same.
【0002】[0002]
【従来の技術】正常な皮膚角質層には通常10〜30%
の水分が含まれており、弾力性と柔軟性が維持されてい
るが、これが年齢や風、湿度などの環境条件の変化等の
原因で10%以下になると、いわゆるドライスキンと呼
ばれる状態になり、皮膚は弾力性を失って、種々のトラ
ブルの原因になることが知られている。2. Description of the Related Art Normal skin stratum corneum usually contains 10 to 30%.
Moisture, and the elasticity and flexibility are maintained, but when this becomes 10% or less due to changes in environmental conditions such as age, wind, humidity, etc., it becomes a so-called dry skin It is known that skin loses elasticity and causes various troubles.
【0003】このドライスキンを防ぐために、従来、種
々の成分を含む化粧料等を用いて皮膚角質層に水分を補
給し、皮膚の生理作用を整えるという試みが広く行われ
ている。[0003] In order to prevent this dry skin, attempts have conventionally been made to replenish moisture to the stratum corneum of the skin using cosmetics and the like containing various components to regulate the physiological action of the skin.
【0004】これら皮膚外部から作用するものには、す
ぐれた保湿効果はもちろんのこと、さわやかな使い心
地、美しい透明な外観、皮膚に負担をかけない等の特性
が要求されるが、今までのところこれらの特性を十分に
満足しているものはない。[0004] These substances acting from the outside of the skin are required to have not only an excellent moisturizing effect, but also a refreshing feeling of use, a beautiful transparent appearance, and no load on the skin. However, none of these characteristics are sufficiently satisfied.
【0005】ところで、近年いわゆる機能性食品の有用
性が指摘されるようになっているが、皮膚角質層の水分
量を増加させる作用を有するものは知られていない。皮
膚角質層の状態は健康状態と関わりが深く、また、人の
健康は食生活によるところが大きい。そこで、食品によ
って皮膚の保湿機構を内側から高めて健康な角質層に導
くことは望ましいことと考えられる。したがって、皮膚
角質層水分量を増加させる作用を有する機能性食品やこ
れを実現させる皮膚角質層水分量増加物質が望まれる。[0005] In recent years, the usefulness of so-called functional foods has been pointed out, but there is no known food having an effect of increasing the water content of the stratum corneum of the skin. The condition of the stratum corneum of the skin is closely related to the state of health, and human health largely depends on eating habits. Therefore, it is considered desirable to enhance the moisturizing mechanism of the skin from the inside with food and to guide it to a healthy stratum corneum. Therefore, a functional food having an effect of increasing the water content of the stratum corneum of the skin and a substance increasing the water content of the skin stratum corneum which realizes this are desired.
【0006】一方、従来よりショウガには血行をよく
し、発汗をうながして嘔吐をしずめたり、食欲を増進さ
せる作用があることが知られている。また、ショウガの
精油には末梢血液循環を促進し、服用後全身が温かくな
り発汗させる作用、胃液分泌を増加させ、胃腸の蠕動を
強めガスを排出させるなどの健胃作用があることが知ら
れている。さらに、血小板凝集抑制作用(特開昭63−
72625号)、炎症防止作用(特開昭61−2639
09号)、美白作用(特開昭61−50909号)、強
心作用(特開昭57−59809号)、鎮痛作用(特公
昭59−1684号)等も知られている。また、ショウ
ガに含まれる成分である6−ジンゲロール(6-gingero
l)や6−ショウガオール(6-shogaol)が、鎮痛作用(特
公昭59−1684号)、強心作用(特公昭64−92
1号)、血小板凝集抑制作用(特開昭62−28392
2号)、抗寄生虫作用(特開平2−4711号)等を有
していることが報告されている。On the other hand, it has been known that ginger has an effect of improving blood circulation, prompting sweating, suppressing vomiting, and increasing appetite. In addition, ginger essential oil is known to promote peripheral blood circulation, warm the whole body after taking it, cause sweating, increase gastric juice secretion, enhance gastrointestinal peristalsis, and excrete gas, etc. ing. Furthermore, the platelet aggregation inhibitory action (Japanese Unexamined Patent Publication No.
No. 72625), an anti-inflammatory effect (JP-A-61-2639)
No. 09), a whitening effect (JP-A-61-50909), a cardiotonic effect (JP-A-57-59809), an analgesic effect (JP-B-59-1684) and the like are also known. In addition, 6-gingerolol, a component contained in ginger, is used.
l) and 6-shogaol have an analgesic effect (JP-B-59-1684) and a cardiotonic effect (JP-B 64-92).
No. 1), platelet aggregation inhibitory action (Japanese Patent Application Laid-Open No. 62-28392)
No. 2) and an antiparasitic effect (Japanese Patent Application Laid-Open No. 2-4711).
【0007】しかし、上記化合物が皮膚角質層水分量を
増加させる作用を有することは知られておらず、これら
を利用して皮膚角質層の水分量を増加させ、乾燥による
肌荒れを防ぎ、みずみずしく潤いのある肌にするという
試みはいまだ報告されていない。[0007] However, it is not known that the above compounds have an effect of increasing the water content of the stratum corneum of the skin. Utilizing these compounds, the water content of the stratum corneum of the skin is increased, the rough skin due to drying is prevented, and the skin is moistened fresh. No attempt has been made to make the skin softer.
【0008】[0008]
【発明が解決しようとする課題】本発明は、上記観点か
らなされたものであり、皮膚角質層の水分量を増加させ
る作用を十分に有し、安全性の高い皮膚角質層水分量増
加剤及びそれを含む組成物を提供することを課題とす
る。DISCLOSURE OF THE INVENTION The present invention has been made in view of the above, and has a sufficient effect of increasing the water content of the stratum corneum of the skin, and is a highly safe skin stratum corneum water content increasing agent. It is an object to provide a composition containing the same.
【0009】[0009]
【課題を解決するための手段】本発明者は、上記課題を
解決するために鋭意研究を行った結果、ショウガ抽出物
に含まれるジンゲロールあるいはショウガオールが皮膚
角質層水分量を増加させる作用を有することを見出し、
本発明に至った。Means for Solving the Problems The present inventors have conducted intensive studies in order to solve the above problems, and as a result, gingerol or gingerol contained in the ginger extract has an effect of increasing the water content of the stratum corneum of the skin. Heading that
The present invention has been reached.
【0010】すなわち本発明は、化4の構造式で表され
る化合物を有効成分として含有する皮膚角質層水分量増
加剤、及びこれを含む組成物である。[0010] That is, the present invention is a skin stratum corneum water content increasing agent containing a compound represented by the structural formula as an active ingredient, and a composition containing the same.
【0011】[0011]
【化4】 Embedded image
【0012】ただし、化4中、Rは、化5又は化6で表
される基を示す(両式においてnは4、6、又は8を表
す)。However, in Chemical Formula 4, R represents a group represented by Chemical Formula 5 or Chemical Formula 6 (n represents 4, 6, or 8 in both formulas).
【0013】[0013]
【化5】 Embedded image
【0014】[0014]
【化6】 Embedded image
【0015】以下、本発明を詳細に説明する。本発明の
皮膚角質層水分量増加剤は、上記化4式で表される化合
物の1種又は2種以上を有効成分とする。尚、化4中、
Rが化5で表されるものはジンゲロール、Rが化6で表
されるものはショウガオールと称される。これらのう
ち、化5式中nが4である6−ショウガオール、化6式
中nが4である6−ジンゲロールが、本発明においては
特に好ましい。Hereinafter, the present invention will be described in detail. The skin horny layer water content increasing agent of the present invention contains one or more compounds represented by the above formula (4) as active ingredients. Incidentally, in Chemical Formula 4,
Those in which R is represented by Chemical Formula 5 are called gingerols, and those in which R is represented by Chemical Formula 6 are called shogaols. Among these, 6-shogaol wherein n is 4 in Chemical Formula 5, and 6-gingerol wherein n is 4 in Chemical Formula 6 are particularly preferred in the present invention.
【0016】上記化合物は、例えばショウガ科の植物で
あるショウガ(生姜)から以下のようにして得ることが
できる。乾燥させたショウガの根茎をエーテルで抽出し
た抽出物を濃縮し、例えばシリカゲルを用いたカラムク
ロマトグラフィーにかけ、ヘキサンとエーテルの濃度勾
配で溶出すると、ヘキサンとエーテルの混合比が1〜
3:1で溶出される分画に主としてショウガオールが、
エーテルで溶出される分画に主としてジンゲロールが得
られる。これらは分取用薄層クロマトグラフィー等によ
りさらに精製することができる。The above compound can be obtained, for example, from ginger (ginger) which is a plant of the ginger family as follows. The extract obtained by extracting the dried ginger rhizome with ether is concentrated and subjected to, for example, column chromatography using silica gel and eluted with a concentration gradient of hexane and ether.
Ginger mainly in the fraction eluted at 3: 1
Gingerol is mainly obtained in the fraction eluted with ether. These can be further purified by preparative thin-layer chromatography or the like.
【0017】上記方法の他に、高速液体クロマトグラフ
ィー等によっても単離、精製が可能である。本発明に
は、精製した上記化合物の他、ショウガ抽出物や各製造
段階のものも同様に使用できる。また、ショウガ抽出物
は、ショウキョウエキスとして市販されており、これを
そのまま、あるいは精製して用いてもよい。In addition to the above method, isolation and purification can be performed by high performance liquid chromatography or the like. In the present invention, besides the above-mentioned purified compound, a ginger extract and those at each production stage can be used as well. The ginger extract is commercially available as ginger extract, and may be used as it is or after purification.
【0018】本発明の皮膚角質層水分量増加剤は、上記
化合物、あるいはショウガ抽出物を基剤に配合すること
により得られる。基剤としては、錠剤、カプセルあるい
はドリンク等の経口用基剤が好ましい。The skin stratum corneum water content increasing agent of the present invention can be obtained by mixing the above compound or ginger extract with a base. The base is preferably an oral base such as a tablet, capsule or drink.
【0019】本発明の皮膚角質層水分量増加剤の投与量
は特に限定されないが、通常は、上記化合物の量として
成人1日当り0.1mg以上であり、好ましくは1〜1
0mgである。この範囲で使用することにより、所期の
効果が期待できる。The dosage of the skin stratum corneum water content increasing agent of the present invention is not particularly limited, but it is usually 0.1 mg or more, preferably 1 to 1 mg per day for an adult.
0 mg. By using in this range, expected effects can be expected.
【0020】又、本発明の組成物は、種々の組成物、例
えば飲食品、医薬品、医薬部外品等に上記皮膚角質層水
分量増加剤を配合したものである。これらの組成物にお
ける上記皮膚角質層水分量増加剤の配合量は、通常は、
上記化合物の量として成人1日当り0.1mg以上であ
り、好ましくは1〜10mgである。特に、ショウガは
古くから食用・薬用に用いられているものであり、長期
連用が可能である。Further, the composition of the present invention is obtained by blending the above-mentioned water content increasing agent for the stratum corneum of the skin with various compositions, for example, foods and drinks, pharmaceuticals, quasi-drugs and the like. The amount of the skin stratum corneum water content increasing agent in these compositions is usually
The amount of the compound is 0.1 mg or more, preferably 1 to 10 mg per adult per day. In particular, ginger has been used for food and medicine for a long time, and long-term continuous use is possible.
【0021】[0021]
【実施例】以下に、本発明の実施例を説明する。はじめ
に、本発明に用いる化合物の製造例を説明する。Embodiments of the present invention will be described below. First, production examples of the compound used in the present invention will be described.
【0022】[0022]
【製造例1】日本薬局方「ショウキョウ」1kgを熱水
10lで3時間還流抽出してその抽出液を濾過し、その
濾液を凍結乾燥して熱水抽出物114gを得た。この熱
水抽出物を1lの巨大網目構造合成吸着剤XAD−2
(オルガノ(株)製)を充填したカラムに通し、非吸着
分画を水でよく洗出した後、吸着分画を2lの99.5
vol%エタノールで溶出した。このカラム吸着分画から
溶媒を減圧下で留去して、7.3gの固形物を得た。[Preparation Example 1] 1 kg of "Kyokyo" from the Japanese Pharmacopoeia was reflux-extracted with 10 l of hot water for 3 hours, the extract was filtered, and the filtrate was freeze-dried to obtain 114 g of a hot water extract. This hot water extract was combined with 1 L of a large network-structured synthetic adsorbent XAD-2.
After passing through a column filled with (manufactured by Organo Co., Ltd.), the non-adsorbed fraction was thoroughly washed with water, and the adsorbed fraction was washed with 2 liters of 99.5.
Elution was performed with vol% ethanol. The solvent was distilled off from the column adsorption fraction under reduced pressure to obtain 7.3 g of a solid.
【0023】この固形物を、分取用逆相カラム(ミリポ
ア社製 μBONDASPHERE 5μ C18-100オンク゛ストローム 19mm×1
5cm)及び溶媒として混合比3:2の水:アセトニトリ
ルを用いた高速液体クロマトグラフィーにより分画し、
6−ジンゲロールが含まれる分画を分取し、減圧下で溶
媒を留去して330mgの6−ジンゲロールを得た。The solid was separated from a preparative reverse phase column (μBONDASPHERE 5 μC18-100 angstrom 19 mm × 1 mm, manufactured by Millipore).
5 cm) and fractionated by high performance liquid chromatography using water: acetonitrile in a mixing ratio of 3: 2 as a solvent,
The fraction containing 6-gingerol was collected and the solvent was distilled off under reduced pressure to obtain 330 mg of 6-gingerol.
【0024】6−ジンゲロールの検出は、n−ヘキサ
ン:酢酸エチル=2:1を展開溶媒とした薄層クロマト
グラフィー、あるいは高速液体クロマトグラフィー(カ
ラム:ミリポア社製 μBONDASPHERE 5μ C18-100オンク゛ス
トローム 3.9mm×15cm、溶出溶媒:混合比3:2の水:アセ
トニトリル、流速:1ml/分、検出波長:210n
m)により行うことができる。尚、この条件では、薄層
クロマトグラフィーではRf=0.6、高速液体クロマ
トグラフィーではRt=11.1分付近に溶出される。The detection of 6-gingerol is performed by thin-layer chromatography using n-hexane: ethyl acetate = 2: 1 as a developing solvent, or high performance liquid chromatography (column: Millipore Co., Ltd., μBONDASPHERE 5 μC18-100 Å, 3.9 mm × 15 cm, elution solvent: water: acetonitrile with a mixing ratio of 3: 2, flow rate: 1 ml / min, detection wavelength: 210 n
m). Under these conditions, Rf is eluted at around Rf = 0.6 in thin layer chromatography and around Rt = 11.1 minutes in high performance liquid chromatography.
【0025】[0025]
【製造例2】日本薬局方「ショウキョウ」1kgをエタ
ノール10lで3時間還流抽出してその抽出液を濾過
し、その濾液を減圧濃縮してエタノール抽出物41gを
得た。このエタノール抽出物を1lの酢酸エチルに懸濁
させ、水1lを加えて液−液抽出を行い、酢酸エチル層
を分取し、溶媒を減圧留去して33.6gの固形物を得
た。[Preparation Example 2] 1 kg of "Shokyo" of the Japanese Pharmacopoeia was refluxed and extracted with 10 l of ethanol for 3 hours, the extract was filtered, and the filtrate was concentrated under reduced pressure to obtain 41 g of an ethanol extract. This ethanol extract was suspended in 1 liter of ethyl acetate, and 1 liter of water was added for liquid-liquid extraction. The ethyl acetate layer was separated, and the solvent was distilled off under reduced pressure to obtain 33.6 g of a solid. .
【0026】この固形物を、製造例1と同様に高速液体
クロマトグラフィーにより分画し、6−ジンゲロールが
含まれる分画を分取し、減圧下で溶媒を留去して2.2
gの6−ジンゲロールを得た。This solid was fractionated by high performance liquid chromatography in the same manner as in Production Example 1, a fraction containing 6-gingerol was collected, and the solvent was distilled off under reduced pressure to obtain 2.2.
g of 6-gingerol were obtained.
【0027】上記製造例1、2で得られた試料が6−ジ
ンゲロールであることを、核磁気共鳴(NMR)スペク
トル、高速液体クロマトグラフィー、薄層クロマトグラ
フィーにより、市販の標品と比較することにより行っ
た。以下に試料のプロトンNMR(in γ-acetone-d6)
のスペクトルを示す。The fact that the sample obtained in Preparation Examples 1 and 2 is 6-gingerol is compared with a commercially available sample by nuclear magnetic resonance (NMR) spectroscopy, high performance liquid chromatography and thin layer chromatography. Was performed. Below is the proton NMR of the sample (in γ-acetone-d 6 )
The spectrum of is shown.
【0028】0.88[3H、トリプレット、J=6ヘル
ツ、-(CH2)4-CH 3] 1.34(センター)[8H、マルチプレット、-CH(OH)-
(CH 2)4-CH3] 2.50[2H、ダブレット、J=7ヘルツ、-C0-CH 2-CH
(OH)-] 2.77[4H、シングレット、Ar-CH 2-CH 2-] 3.81[3H、シングレット、-O-CH 3-] 4.00[1H、マルチプレット、-CH(OH)-] 6.62−6.82[3H、マルチプレット、3×アロマ
ティックH][0028] 0.88 [3H, triplet, J = 6 Hz, - (CH 2) 4 -C H 3] 1.34 ( center) [8H, multiplet, -CH (OH) -
(C H 2) 4 -CH 3 ] 2.50 [2H, doublet, J = 7 Hz, -C0-C H 2 -CH
(OH) -] 2.77 [4H , singlet, Ar-C H 2 -C H 2 -] 3.81 [3H, singlet, -OC H 3 -] 4.00 [ 1H, multiplet, -C H (OH)-] 6.62-6.82 [3H, multiplet, 3x aromatic H]
【0029】また、雄性マウスに対する急性毒性は、経
口投与で100mg/kg以上であった。尚、6−ショ
ウガオールについても、急性毒性は極めて少ないことが
知られている(特公昭59−1684号等)。The acute toxicity to male mice was 100 mg / kg or more by oral administration. It is also known that 6-shogaol has extremely low acute toxicity (Japanese Patent Publication No. 59-1684, etc.).
【0030】[0030]
【実施例1】1%カルボキシメチルセルロースナトリウ
ム(cmc−Na)水溶液50mlに、6−ジンゲロー
ル15mgを溶解して皮膚角層水分量増加剤を製造し
た。Example 1 15 mg of 6-gingerol was dissolved in 50 ml of a 1% aqueous solution of sodium carboxymethylcellulose (cmc-Na) to prepare a skin horny layer water content increasing agent.
【0031】次に、この皮膚角質層水分量増加剤の効果
を示す。19匹の雄性ヘアレスマウス(体重約35g、
25週齢)を、23.0±1.0℃、湿度50±5%に
調節された室内で、1時間放置してこの環境に順応させ
た後、胸部皮膚角質層水分量を測定した。その後10匹
には上記皮膚角質層水分量増加剤0.5mlを、残りの
9匹には比較例として1%カルボキシメチルセルロース
ナトリウム水溶液0.5mlを、各々経口投与した。投
与後7時間の胸部皮膚角質層水分量を経時的に(15
分、30分、45分、1時間、1.5時間、3時間、5
時間、7時間)測定した。Next, the effects of the skin stratum corneum water content increasing agent will be described. 19 male hairless mice (weight about 35 g,
(25 weeks old) was left for 1 hour in a room adjusted to 23.0 ± 1.0 ° C. and 50 ± 5% humidity to adjust to this environment, and then the water content of the horny layer of the thoracic skin was measured. Thereafter, 10 mice were orally administered with 0.5 ml of the above-mentioned skin stratum corneum water content increasing agent, and the remaining 9 animals were orally administered with 0.5 ml of a 1% aqueous solution of sodium carboxymethylcellulose as a comparative example. The water content of the stratum corneum of the thoracic skin at 7 hours after the administration was measured over time (15
Minutes, 30 minutes, 45 minutes, 1 hour, 1.5 hours, 3 hours, 5
Time, 7 hours).
【0032】尚、胸部皮膚角質層水分量は、マウスを仰
臥位に保定し胸骨体部の皮膚に低周波型角質層水分測定
装置(Courage+Khazaka electronic社製 Corneometer C
M820PC)の検出部を当てて測定した。また、固体差をな
くすため試料投与前のarbitrary units (a.u.) 値を基
準として、この a.u.値に対する試料投与後の a.u.値の
百分率(%)を求め、それを用いてデータ処理を行っ
た。尚、有意差検定は、スチューデントt検定により行
った。The amount of water in the stratum corneum of the thoracic skin was measured by holding the mouse in a supine position and applying a low-frequency type stratum corneum moisture meter (Courage + Khazaka electronic Co. Corneometer C) to the skin of the sternum body.
M820PC). Further, in order to eliminate individual differences, the percentage (%) of the au value after the sample administration with respect to the au value was determined based on the arbitrary units (au) value before the sample administration, and data processing was performed using the percentage. In addition, the significant difference test was performed by the Student's t test.
【0033】試料投与前の a.u.値に対する試料投与後
の a.u.値の百分率(%)の、各群(投与群とコントロ
ール群)の平均値を標準偏差とともに図1に示す。図
中、*印は危険率5%未満で、**印は危険率1%未満
で、それぞれ有意差があることを示す。FIG. 1 shows the average value of the percentage (%) of the au value after the sample administration to the au value before the sample administration for each group (administration group and control group) together with the standard deviation. In the figure, * indicates that the risk rate is less than 5%, and ** indicates that the risk rate is less than 1%, each of which has a significant difference.
【0034】この結果から、本発明の剤を投与されたヘ
アレスマウスは、カルボキシメチルセルロースナトリウ
ム水溶液のみを投与されたヘアレスマウスに比べ、投与
後約45分から約1時間の間、有意に皮膚角質層水分が
増加していることが明らかである。尚、ヘアレスマウス
には汗腺がないので、上記試験により検出された水分量
は、発汗によるものではなく、皮膚角質層の水分が増加
したものと考えられる。From these results, it can be seen that the hairless mice to which the agent of the present invention was administered had a significantly higher skin horny layer water content for about 45 minutes to about 1 hour after administration than the hairless mice to which only the aqueous solution of sodium carboxymethylcellulose was administered. It is clear that has increased. Since the hairless mouse has no sweat glands, the amount of water detected in the above test is not due to sweating, but is considered to be due to an increase in water in the stratum corneum of the skin.
【0035】[0035]
【発明の効果】本発明の皮膚角質層水分量増加剤及びこ
れを含む組成物は、皮膚角質層の水分量を増加させる作
用にすぐれ、しかも安全性が高い。EFFECTS OF THE INVENTION The agent for increasing the water content of the stratum corneum of the present invention and the composition containing the same are excellent in the action of increasing the water content of the stratum corneum of the skin and have high safety.
【図1】 ヘアレスマウス胸部皮膚角質層水分量の投与
前に対する投与後の百分率(%)の平均値と標準偏差の
経時変化を示す図。BRIEF DESCRIPTION OF THE DRAWINGS FIG. 1 is a graph showing the change over time in the mean value and the standard deviation of the percentage (%) of hairless mouse horny skin stratum corneum after administration compared to before administration.
図中*印は危険率5%未満で、**印は危険率1%未満
で、それぞれ有意差があることを示す。In the figure, the symbol * indicates that the risk factor is less than 5%, and the symbol ** indicates that the risk factor is less than 1%, each of which has a significant difference.
───────────────────────────────────────────────────── フロントページの続き (56)参考文献 特開 平6−239758(JP,A) 特開 平6−239736(JP,A) 特開 平6−183959(JP,A) 特開 平1−207256(JP,A) 特開 平1−96121(JP,A) 特開 昭59−106277(JP,A) (58)調査した分野(Int.Cl.7,DB名) A61K 31/12 - 31/125 A61K 7/00 - 7/48 A61K 35/78 CA(STN) CAOLD(STN)──────────────────────────────────────────────────続 き Continuation of front page (56) References JP-A-6-239758 (JP, A) JP-A-6-239736 (JP, A) JP-A-6-183959 (JP, A) 207256 (JP, A) JP-A-1-96121 (JP, A) JP-A-59-106277 (JP, A) (58) Fields investigated (Int. Cl. 7 , DB name) A61K 31/12-31 / 125 A61K 7/00-7/48 A61K 35/78 CA (STN) CAOLD (STN)
Claims (2)
分として含有する皮膚角質層水分量増加剤。 【化1】 ただし、化1中、Rは、化2又は化3で表される基を示
す(両式においてnは4、6、又は8を表す)。 【化2】 【化3】 1. An agent for increasing the water content of the stratum corneum of the skin, comprising a compound represented by the structural formula 1 as an active ingredient. Embedded image Here, in Chemical formula 1, R represents a group represented by Chemical formula 2 or Chemical formula 3 (n represents 4, 6, or 8 in both formulas). Embedded image Embedded image
を含有する組成物。2. A composition comprising the skin stratum corneum water content increasing agent according to claim 1.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP5029477A JP3072584B2 (en) | 1993-02-18 | 1993-02-18 | Skin stratum corneum water content increasing agent |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP5029477A JP3072584B2 (en) | 1993-02-18 | 1993-02-18 | Skin stratum corneum water content increasing agent |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH06239729A JPH06239729A (en) | 1994-08-30 |
JP3072584B2 true JP3072584B2 (en) | 2000-07-31 |
Family
ID=12277173
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP5029477A Expired - Lifetime JP3072584B2 (en) | 1993-02-18 | 1993-02-18 | Skin stratum corneum water content increasing agent |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP3072584B2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102418909B1 (en) * | 2015-12-31 | 2022-07-07 | 주식회사 엘지생활건강 | Composition for improving skin conditions comprising 8-Gingerol |
-
1993
- 1993-02-18 JP JP5029477A patent/JP3072584B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JPH06239729A (en) | 1994-08-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69919287T2 (en) | Ethyl acetate extract of indigo plant | |
EP2008662B1 (en) | Lipolysis stimulator | |
JP4495406B2 (en) | Sendangusa plant extract-containing composition | |
Prior et al. | Self-poisoning with oral salbutamol. | |
JP3164455B2 (en) | Stratum corneum repair promoter | |
JP2001507712A (en) | Use of Shogaols and Gingerols in the Production of Deodorizing Compositions | |
KR20050078393A (en) | Beauty product manufacturing method for using very beginning milk and arbutin and thereof product | |
JP3233776B2 (en) | Skin whitening agent | |
US5288485A (en) | Vasodilating agent | |
JP3072584B2 (en) | Skin stratum corneum water content increasing agent | |
EP0415327B1 (en) | Vasodilating agent | |
CN110898201A (en) | A topical Chinese medicinal composition for removing food stagnation in children, and its preparation method | |
JPH05502457A (en) | Kava kava extracts, their manufacturing process and uses | |
JP3183741B2 (en) | Complexion improver | |
JPH06183959A (en) | Blood circulation promoter | |
JP2004137218A (en) | Lipolysis promoter, and skin care preparation for external use and food and drink product using the same | |
KR100234494B1 (en) | Novel composition containing crude-drug complex and the process for preparing them | |
US20050118287A1 (en) | Use of a vanilloid as an anti-snoring element | |
JP5325727B2 (en) | Sendangusa plant extract-containing composition | |
JPH0582365B2 (en) | ||
WO2012137223A1 (en) | A synergistic herbal extract composition for use in treating bloating | |
RU2104021C1 (en) | Method to increase pelotherapy efficiency | |
RU2201229C1 (en) | Method of body sanitation | |
JPH01279818A (en) | White hair blackening agent | |
JP2001178409A (en) | Red bean essence-containing supplementary health food |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
EXPY | Cancellation because of completion of term |